P/B
0,7
Creative Medical Technology Holdings
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
$5.8M
Market Cap • 9/15/2026
1998
(28 years)
Founded
2009
(17 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
1944,8
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
2,7
EPS
—
Market Cap
Market Cap
5,8M
EV
-3M
EV/Revenue
-988,8
EV/EBITDA
0,5
EV/EBIT
0,5
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
0%
Total Yield
0%
Payout
0%
Retained Earnings
-73,5M
Profitability
Gross Margin
66,9%
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
67203%
Capex/Revenue
0%
Capex/D&A
0%
Capex/OCF
0%
SBC/OCF
—
% PPE
0%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Revenue 5Y
-50,8%
CAGR Op. Income 5Y
35,1%
CAGR Net Income 5Y
-14,6%
CAGR EPS 5Y
-67,5%
CAGR OCF 5Y
68,5%
Leverage
N.D./EBITDA
1,4
Debt/Equity
0%
Current Ratio
12,9
Quick Ratio
12,8
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!